UNM Cancer Center administration for the CCSG involves three sets of integrated teams: 1) the research administration team led by Rae Ahn Paden, the Associate Director of Research Administration and Dr. Larry Sklar, Associate Director of Basic Research; 2) the shared resource team led by Dr. Scott Ness; and 3) the Clinical Research Committee led by Dr. Robert Hromas, the Deputy Director for Clinical Affairs and Translational Research. These teams are coordinated through the Senior Leadership Executive Committee that sets priorities for the UNM Cancer Center through frequent meetings and an annual budget hearing with appropriate team representatives. UNM Cancer Center Research Administration (CCRA) supports 117 UNM Cancer Center Members, the four research programs and the six shared resources as well as a full complement of clinical trial and support activities. CCRA provides key services to facilitate and enhance scientific productivity and collaboration. CCRA, through Cancer Center Fiscal Services and CFO Bradley Mucek provides pre- and post-award management of grants and contracts and financial management of university and foundation accounts. CCRA through Paden also develops and maintains the Cancer Center portion of the UNM computer network, maintains Cancer Center databases and infomnatics infrastructure, oversees human resource management, the strategic planning process, and the research buildings. The Research Administration Team is responsible for: 1) coordinating seminars, including the monthly Distinguished Cancer Research lecture; 2) disseminating notices of research events through email and a web-based calendar; 3) disseminating notices of external and internal funding opportunities; 4) planning, co-ordination and execution of multiproject program grants; 5) supporting Cancer Center Research Programs by scheduling and staffing meetings, recording meeting minutes, maintaining membership lists, organizing program retreats; 6) coordinating faculty recruiting visits with Cancer Center members and Academic or Clinical Departments; 7) coordinating the annual Cancer Center retreat and workshops; 8) coordinating ESAB meetings; and 9) supporting activities related to the CCSG including data bases, extramural funding tables, biosketches and publications for the Cancer Center research website and the CCSG. The Shared Resource Team oversees Shared Resources by maintaining databases of Shared Resource users, services, fees, and grant support for the CCSG. In conjunction with Cancer Center administration the team is responsible for 1) supporting research infrastructure; 2) coordinating faculty effort and salary support for UNM Cancer Center and the home department of the Resource Directors; 3) tracking resource support as distributed throughout the institution, tracking resource revenues and expenses, and developing business plans; 4) creating an interface for Resource users by tracking usage, generating invoices, and implementing the co-pay mechanism; 5) centralizing resource ordering, receiving, and service agreements and 6) monthly planning meetings with shared resource directors. The Clinical Research Committee sen/es as the oversight committee for all clinical research at the Cancer Center. To implement strategic planning, quality control, and co-ordination it oversees: 1) CPDMI, 2) Protocol Review and Monitoring System, 3) Protocol Specific Research Support, 4) Data Safety and Monitoring, and 5) the clinical working groups.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA118100-08S2
Application #
8545056
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
8
Fiscal Year
2012
Total Cost
$4,168
Indirect Cost
$1,408
Name
University of New Mexico Health Sciences Center
Department
Type
DUNS #
829868723
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Steffen, Laurie E; Du, Ruofei; Gammon, Amanda et al. (2017) Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode. Cancer Epidemiol Biomarkers Prev 26:1772-1780
Cleyrat, C├ędric; Girard, Romain; Choi, Eun H et al. (2017) Gene editing rescue of a novel MPL mutant associated with congenital amegakaryocytic thrombocytopenia. Blood Adv 1:1815-1826
Oruganti, S R; Torres, D J; Krebsbach, S et al. (2017) CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS. Leukemia 31:255-258
Belinsky, Steven A; Leng, Shuguang; Wu, Guodong et al. (2017) Gene Methylation Biomarkers in Sputum and Plasma as Predictors for Lung Cancer Recurrence. Cancer Prev Res (Phila) 10:635-640
Hill, Deirdre A; Barry, Marc; Wiggins, Charles et al. (2017) Estrogen receptor quantitative measures and breast cancer survival. Breast Cancer Res Treat 166:855-864
Meyer, Matthias R; Rosemann, Thomas; Barton, Matthias et al. (2017) GPER Mediates Functional Endothelial Aging in Renal Arteries. Pharmacology 100:188-193
Flores, Kristina G; Steffen, Laurie E; McLouth, Christopher J et al. (2017) Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families. J Genet Couns 26:480-490
Wang, Jing; Samuels, David C; Zhao, Shilin et al. (2017) Current Research on Non-Coding Ribonucleic Acid (RNA). Genes (Basel) 8:
Leng, Shuguang; Wu, Guodong; Klinge, Donna M et al. (2017) Gene methylation biomarkers in sputum as a classifier for lung cancer risk. Oncotarget 8:63978-63985
Kimura, Tomonori; Jia, Jingyue; Kumar, Suresh et al. (2017) Dedicated SNAREs and specialized TRIM cargo receptors mediate secretory autophagy. EMBO J 36:42-60

Showing the most recent 10 out of 272 publications